These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33506760)

  • 21. Conformational and Thermodynamic Landscape of GPCR Activation from Theory and Computation.
    Dong SS; Goddard WA; Abrol R
    Biophys J; 2016 Jun; 110(12):2618-2629. PubMed ID: 27332120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation mechanism of the β2-adrenergic receptor.
    Dror RO; Arlow DH; Maragakis P; Mildorf TJ; Pan AC; Xu H; Borhani DW; Shaw DE
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18684-9. PubMed ID: 22031696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 receptor.
    Nivedha AK; Lee S; Vaidehi N
    J Mol Graph Model; 2023 Jan; 118():108365. PubMed ID: 36335829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
    Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
    J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DIRECT-ID: An automated method to identify and quantify conformational variations--application to β2 -adrenergic GPCR.
    Lakkaraju SK; Lemkul JA; Huang J; MacKerell AD
    J Comput Chem; 2016 Feb; 37(4):416-25. PubMed ID: 26558323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand entry and exit pathways in the beta2-adrenergic receptor.
    Wang T; Duan Y
    J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of β
    Ma X; Hu Y; Batebi H; Heng J; Xu J; Liu X; Niu X; Li H; Hildebrand PW; Jin C; Kobilka BK
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23096-23105. PubMed ID: 32868434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-binding affinity of alternative conformers of human β
    Dilcan G; Doruker P; Akten ED
    Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
    Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
    J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation-Induced Reorganization of Energy Transport Networks in the β
    Poudel H; Leitner DM
    J Phys Chem B; 2021 Jun; 125(24):6522-6531. PubMed ID: 34106712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the influence of external factors on the conformational dynamics of rhodopsin-like receptors by means of molecular dynamics simulation.
    Novikov GV; Sivozhelezov VS; Kolesnikov SS; Shaitan KV
    J Recept Signal Transduct Res; 2014 Apr; 34(2):104-18. PubMed ID: 24495290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes.
    Isin B; Estiu G; Wiest O; Oltvai ZN
    PLoS One; 2012; 7(12):e50186. PubMed ID: 23300522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of allosteric regulation of β
    Manna M; Niemelä M; Tynkkynen J; Javanainen M; Kulig W; Müller DJ; Rog T; Vattulainen I
    Elife; 2016 Nov; 5():. PubMed ID: 27897972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular dynamics simulation of β-adrenoceptors and their coupled G proteins.
    Li ZY; Su CY; Ding B
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6346-6351. PubMed ID: 31364142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-time analysis of ternary complex on particles: direct evidence for partial agonism at the agonist-receptor-G protein complex assembly step of signal transduction.
    Simons PC; Biggs SM; Waller A; Foutz T; Cimino DF; Guo Q; Neubig RR; Tang WJ; Prossnitz ER; Sklar LA
    J Biol Chem; 2004 Apr; 279(14):13514-21. PubMed ID: 14726530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
    Rosenbaum DM; Zhang C; Lyons JA; Holl R; Aragao D; Arlow DH; Rasmussen SG; Choi HJ; Devree BT; Sunahara RK; Chae PS; Gellman SH; Dror RO; Shaw DE; Weis WI; Caffrey M; Gmeiner P; Kobilka BK
    Nature; 2011 Jan; 469(7329):236-40. PubMed ID: 21228876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of the orthosteric ligands binding on the conformational dynamics of the B-2-adrenergic receptor by means of essential dynamics sampling simulation].
    Novikov GV; Sivozhelezov VS; Shaitan KV
    Mol Biol (Mosk); 2014; 48(3):463-79. PubMed ID: 25831896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors.
    Gouldson PR; Snell CR; Reynolds CA
    J Med Chem; 1997 Nov; 40(24):3871-86. PubMed ID: 9397168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
    Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational study on the different ligands induced conformation change of β2 adrenergic receptor-Gs protein complex.
    Bai Q; Zhang Y; Ban Y; Liu H; Yao X
    PLoS One; 2013; 8(7):e68138. PubMed ID: 23922653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.